甘精胰岛素联合格列吡嗪治疗2型糖尿病的临床效果分析

The clinical analysis of the efficacy for refined insulin plus glipizide in the treatment of type 2 diabetes

目的:探讨甘精胰岛素联合格列吡嗪治疗2型糖尿病的临床疗效。方法:选取2型糖尿病患者130例,随机分为有可比性的两组各65例,分别给与甘精胰岛素联合格列吡嗪治疗以及诺和灵N联合格列吡嗪治疗。对两组患者治疗效果进行比较。结果:经过12周的治疗,观察组患者血糖达标率明显高于对照组,夜间低血糖事件发生率则明显低于对照组,两组患者比较差异明显,有统计学意义(P<0.05)。结论:使用甘精胰岛素联合格列吡嗪治疗2型糖尿病安全有效。

Objective：To investigate the clinical efficacy for refined insulin plus glipizide in the treatment of type 2 diabetes. Methods ：130 ca- ses of type 2 diabetes were randomly divided into the comparability of two groups of 65 cases. They were respectively given the joint the Gan arginine joint glipizide treatment,and Novolin N glipizide treatment. The treatment effect of the two groups was compared. Results：Mter 12 weeks of treatment, the blood glucose rate of the observation group was significantly higher than the control group. The event of nocturnal hypoglycemia was signifi- cantly lower than the control group, the difference for the two groups of patients was statistically significant （P 〈 0.05 ）. Conclusion：The use of fine insulin joint grid glipizide treatment of type 2 diabetes is safe and effective.